Last reviewed · How we verify

Diclofenac and Atropine combination drug

Brigham and Women's Hospital · Phase 3 active Small molecule

Diclofenac and Atropine combination drug is a NSAID + Anticholinergic combination Small molecule drug developed by Brigham and Women's Hospital. It is currently in Phase 3 development for Abdominal pain and cramping associated with gastrointestinal disorders, Biliary or renal colic with antispasmodic benefit. Also known as: Analgesic drug, Combination drug, Test drug, Diclofenac and atropine.

This combination drug reduces inflammation and pain through COX inhibition (diclofenac) while simultaneously blocking muscarinic acetylcholine receptors (atropine) to modulate parasympathetic activity.

This combination drug reduces inflammation and pain through COX inhibition (diclofenac) while simultaneously blocking muscarinic acetylcholine receptors (atropine) to modulate parasympathetic activity. Used for Abdominal pain and cramping associated with gastrointestinal disorders, Biliary or renal colic with antispasmodic benefit.

At a glance

Generic nameDiclofenac and Atropine combination drug
Also known asAnalgesic drug, Combination drug, Test drug, Diclofenac and atropine, Atropine and diclofenac
SponsorBrigham and Women's Hospital
Drug classNSAID + Anticholinergic combination
TargetCOX-1/COX-2 (diclofenac); Muscarinic acetylcholine receptors (atropine)
ModalitySmall molecule
Therapeutic areaPain Management / Gastroenterology
PhasePhase 3

Mechanism of action

Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes, reducing prostaglandin synthesis and thereby decreasing inflammation and pain. Atropine is an anticholinergic agent that blocks muscarinic acetylcholine receptors, reducing parasympathetic effects such as smooth muscle contraction and secretions. The combination is designed to provide both anti-inflammatory analgesia and antispasmodic effects, potentially useful in conditions involving both pain/inflammation and smooth muscle dysfunction.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Diclofenac and Atropine combination drug

What is Diclofenac and Atropine combination drug?

Diclofenac and Atropine combination drug is a NSAID + Anticholinergic combination drug developed by Brigham and Women's Hospital, indicated for Abdominal pain and cramping associated with gastrointestinal disorders, Biliary or renal colic with antispasmodic benefit.

How does Diclofenac and Atropine combination drug work?

This combination drug reduces inflammation and pain through COX inhibition (diclofenac) while simultaneously blocking muscarinic acetylcholine receptors (atropine) to modulate parasympathetic activity.

What is Diclofenac and Atropine combination drug used for?

Diclofenac and Atropine combination drug is indicated for Abdominal pain and cramping associated with gastrointestinal disorders, Biliary or renal colic with antispasmodic benefit.

Who makes Diclofenac and Atropine combination drug?

Diclofenac and Atropine combination drug is developed by Brigham and Women's Hospital (see full Brigham and Women's Hospital pipeline at /company/brigham-and-women-s-hospital).

Is Diclofenac and Atropine combination drug also known as anything else?

Diclofenac and Atropine combination drug is also known as Analgesic drug, Combination drug, Test drug, Diclofenac and atropine, Atropine and diclofenac.

What drug class is Diclofenac and Atropine combination drug in?

Diclofenac and Atropine combination drug belongs to the NSAID + Anticholinergic combination class. See all NSAID + Anticholinergic combination drugs at /class/nsaid-anticholinergic-combination.

What development phase is Diclofenac and Atropine combination drug in?

Diclofenac and Atropine combination drug is in Phase 3.

What are the side effects of Diclofenac and Atropine combination drug?

Common side effects of Diclofenac and Atropine combination drug include Gastrointestinal upset (nausea, dyspepsia), Anticholinergic effects (dry mouth, urinary retention, tachycardia), Dizziness or blurred vision, NSAID-related renal or cardiovascular effects.

What does Diclofenac and Atropine combination drug target?

Diclofenac and Atropine combination drug targets COX-1/COX-2 (diclofenac); Muscarinic acetylcholine receptors (atropine) and is a NSAID + Anticholinergic combination.

Related